Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
The production suspension impacts commercial and clinical trial supply
Upon closing, the Quakertown business will become an independent company called Microsize
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
Subscribe To Our Newsletter & Stay Updated